- By FYH News Team
[ad_1]
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/18/2022
March 18, 2022 5:22 AM EDT
FILE PHOTO: A man walks past the logo of Shimizu Corp outside a construction site in Tokyo, Japan, December 18, 2017. REUTERS/Toru Hanai
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
By Makiko Yamazaki
TOKYO (Reuters) – A U.S.-based fund has called for Japan’s Shimizu Corp to halt a $190 million bid to take control of road builder Nippon Road Co Ltd, saying the deal would be unfair to minority shareholders and go against governance reform.
In a letter to Nippon Road’s board this week that was seen by Reuters, Kaname Capital objected to Shimizu’s bid to double its holding to 50.1%.
Kaname, which owns 1.8% of Nippon Road, said the deal would put minority shareholders at a disadvantage by turning them into investors in a listed subsidiary.
“A partial bid is unsatisfactory. Only a 100% bid allows for fair and equal treatment of all shareholders,” the Boston-based long-only fund said in its letter.
The offer price of 10,000 yen ($84.13) a share was too low given Nippon Road’s cash on hand, shareholdings and other assets, Kaname said, putting the share value closer to 12,500 yen.
(Reporting by Makiko Yamazaki; Editing by David Dolan and Kim Coghill)
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Jessica Wilson
- Subash Kafle















